Your browser doesn't support javascript.
loading
Prediction of relapse activity when switching to cladribine for multiple sclerosis.
Zhong, Michael; van der Walt, Anneke; Monif, Mastura; Hodgkinson, Suzanne; Eichau, Sara; Kalincik, Tomas; Lechner-Scott, Jeannette; Buzzard, Katherine; Skibina, Olga; Van Pesch, Vincent; Butler, Ernest; Prevost, Julie; Girard, Marc; Oh, Jiwon; Butzkueven, Helmut; Jokubaitis, Vilija.
Affiliation
  • Zhong M; Central Clinical School, Monash University, Melbourne, VIC, Australia/Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia.
  • van der Walt A; Central Clinical School, Monash University, Melbourne, VIC, Australia/Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia.
  • Monif M; Central Clinical School, Monash University, Melbourne, VIC, Australia/Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia/MS Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Hodgkinson S; Liverpool Hospital, Sydney, NSW, Australia.
  • Eichau S; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Kalincik T; MS Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia/CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
  • Lechner-Scott J; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia/Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, NSW, Australia.
  • Buzzard K; MS Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia/Department of Neurosciences, Eastern Health Clinical School, Monash University, Box Hill Hospital, Melbourne, VIC, Australia.
  • Skibina O; Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia/Department of Neurosciences, Eastern Health Clinical School, Monash University, Box Hill Hospital, Melbourne, VIC, Australia.
  • Van Pesch V; Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
  • Butler E; Monash Medical Centre, Melbourne, VIC, Australia.
  • Prevost J; CSSS Saint-Jérôme, Saint-Jérôme, QC, Canada.
  • Girard M; CHUM and Universite de Montreal, Montreal, QC, Canada.
  • Oh J; Division of Neurology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Butzkueven H; Central Clinical School, Monash University, Melbourne, VIC, Australia/Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia.
  • Jokubaitis V; Central Clinical School, Monash University, Melbourne, VIC, Australia/Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia.
Mult Scler ; 29(1): 119-129, 2023 01.
Article in En | MEDLINE | ID: mdl-35894247
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2023 Type: Article